Prices delayed by at least 15 minutes | Print
Xtrackers (Ie) Public Limited Company X MSCI GENOMIC HC INNOV UCITS ETF 1C
Open
$43.685
Previous close
$43.40
Trade high
$43.685
Income frequency
-
Year low
$31.23
Year high
$46.095
Replication method
Physical Full
Volume
1
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.3
ISIN
IE000KD0BZ68
Share price
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| Illumina Inc | 5.87 |
| Natera Inc | 5.59 |
| Agilent Technologies Inc | 4.88 |
| Moderna Inc | 4.86 |
| Danaher Corp | 4.61 |
| Lonza Group Ltd | 4.19 |
| Vertex Pharmaceuticals Inc | 4.17 |
| GSK PLC ADR | 4.01 |
| Guardant Health Inc | 3.90 |
| Roche Holding AG Ordinary Shares new | 3.85 |
Investment objective
The investment objective of the Fund is to track the performance before fees and expenses of an index which is designed to reflect the performance of the shares of large, medium, and small-capitalisation companies that derive, or are expected to derive, significant revenues from technological innovation in the genomic healthcare sector and which promote, among other characteristics, environmental and social characteristics.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.